Lead-induced changes in human erythrocytes and lymphocytes.

Area of Science:

• Environmental toxicology
• Cellular and molecular toxicology
• Biochemistry

Background:

• Lead exposure is a significant public health concern.
• Understanding lead's cellular mechanisms is crucial for risk assessment.
• Erythrocytes and lymphocytes are key targets for lead toxicity.

Purpose of the Study:

• To investigate the effect of lead acetate on reactive oxygen species (ROS) production in human erythrocytes.
• To evaluate lead-induced modifications of proteins and lipids in erythrocyte and lymphocyte membranes.
• To determine the impact of lead on the physicochemical properties of cell membranes.

Main Methods:

• Chemiluminescence measurements to assess ROS production.
• Fluorescence probes (N-(1-pyrene)maleimide, laurdan, pyrene) to analyze membrane lipid and protein alterations.
• Incubation of human erythrocytes and lymphocytes with varying lead acetate concentrations.

Main Results:

• Lead acetate (1-50 microM) did not significantly increase ROS production in erythrocytes.
• Lead acetate treatment reduced total fluorescence intensity and PM excimer/monomer ratio.
• Generalized fluorescence polarization of laurdan decreased, indicating altered membrane fluidity.
• Pyrene excimerization coefficient increased, suggesting changes in membrane protein organization.

Conclusions:

• Low lead concentrations do not induce significant ROS production in erythrocytes in vitro.
• Lead acetate alters the physicochemical state of proteins and lipids in erythrocyte and lymphocyte membranes.
• These membrane changes can affect enzymatic activity, receptor function, and overall cell function.